Brentuximab (Anti-TNFRSF8 / CD30)

Ask supplier a question | View on supplier's website

Brentuximab (Anti-TNFRSF8 / CD30) is a chimeric monoclonal antibody targeting anti-CD30 with antineoplastic activity. It has the potential to alter the disease course of non-MF/SS CTCLs. MW : 145.38 KD.

Supplier	Selleck Chemicals
Product #	A2322
Sku #	A2322-1mg
Pricing	1mg, $470.00

Feedback